Is the IDH Mutation a Good Target for Chondrosarcoma Treatment?

Overview of attention for article published in Current Molecular Biology Reports, January 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)

Mentioned by

twitter: 11 X users

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 20 publications that cite this research output.

20

The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.

Are IDH1 R132 Mutations Associated With Poor Prognosis in Patients With Chondrosarcoma of the Bone?

Article in Clinical Orthopaedics and Related Research® (January 2024)

IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience

Article in BMC Cancer (September 2023)

Structure-based discovery of IHMT-IDH1-053 as a potent irreversible IDH1 mutant selective inhibitor

Article in European Journal of Medicinal Chemistry (May 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.